02525nam a22004214a 4500001001200000003000800012006001900020007001500039008004100054010001700095015001900112016002000131016001800151020003100169020002800200040002100228035002000249050002500269082001900294100002300313245014700336250001200483260005800495300002200553504005100575505041700626505034401043505026601387533015201653650002601805650002501831650002701856655002901883700003101912710001701943856012601960999001702086ebr10375127CaPaEBRm u cr cn|||||||||050504s2006 enka sb 001 0 eng  z 2005012980 aGBA6163922bnb7 z1012473452DNLM7 z0133859352Uk z9780195155648 (alk. paper) z0195155645 (alk. paper) aCaPaEBRcCaPaEBR a(OCoLC)7179428014aRC694.3b.B39 2006eb04a616.1/35062221 aBecker, Richard C.10aFibrinolytic and antithrombotic therapyh[electronic resource] :btheory, practice, and management /cRichard C. Becker, Frederick A. Spencer. a2nd ed. aOxford ;aNew York :bOxford University Press,c2006. ax, 410 p. :bill. aIncludes bibliographical references and index.0 aHistorical perspectives in hemostasis, coagulation and fibrinolysis -- Vascular biology, thromboresistance and inflammation -- Atherosclerosis and arterial thrombosis -- Venous thromboembolism -- Cardiac chamber, aortic and valvular thromboembolism -- Fibrinolytic agents -- Aspirin -- Clopidogrel -- Platelet Glycoprotein IIb/IIIa receptor antagonists -- Aggrenox and cilostazol -- Novel platelet antagonists --0 aCombination pharmacotherapy -- Facilitated percutaneous coronary intervention -- Thrombin-directed therapy -- Factor Xa inhibitors -- Direct thrombin inhibitors -- Novel anticoagulants -- Acute coronary syndromes -- Peripheral vascular disease and stroke -- Valvular heart disease and atrial fibrillation -- Plaque-stabilizing therapies --0 aVenous thromboembolism prophylaxis -- Venous thromboembolism treatment -- Fundamentals and patient evaluation -- Platelet antagonists -- Anticoagulants -- Anticoagulation clinics and self-testing -- Platelet antagonists -- Anticoagulants -- Fibrinolytic agents. aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2013.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aThrombolytic therapy. 0aFibrinolytic agents. 0aThrombosisxTreatment. 7aElectronic books.2local1 aSpencer, Fredrick A.,cMD.2 aebrary, Inc.40uhttp://site.ebrary.com/lib/rucke/Doc?id=10375127zAn electronic book accessible through the World Wide Web; click to view c99684d99684